| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 9 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 9 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 9 |
| 3 | RITUXIMAB | 8 |
| 4 | BUSULFAN | 7 |
| 5 | AZACITIDINE | 4 |
| 6 | AZACITIDINE FOR | 4 |
| 7 | VENETOCLAX | 4 |
| 8 | DEXAMETHASONE | 3 |
| 9 | DEXAMETHASONE 1.5 MG | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BACILLUS CALMETTE-GUERIN | 2 | 0.0011 |
| 1 | PSYLLIUM HUSK | 1 | 0.0007 |
| 2 | BUSULFAN | 7 | 0.0004 |
| 3 | MITOXANTRONE HYDROCHLORIDE | 1 | 0.0002 |
| 4 | EPIRUBICIN HYDROCHLORIDE | 1 | 0.0002 |
| 5 | AZACITIDINE | 4 | 0.0001 |
| 6 | SELINEXOR | 1 | 0.0001 |
| 7 | DASATINIB | 1 | 0.0001 |
| 8 | MAGNESIUM SULFATE HEPTAHYDRATE | 1 | 0.0001 |
| 9 | SIROLIMUS | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] | 2 | 0.0011 |
| 1 | Nuclear Export Inhibitor [EPC] | 1 | 0.0001 |
| 2 | BCL-2 Inhibitor [EPC] | 4 | 0.0001 |
| 3 | Alkylating Drug [EPC] | 13 | 0.0001 |
| 4 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 5 | Antimetabolite Immunosuppressant [EPC] | 1 | 0.0000 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 8 | 0.0000 |
| 7 | Pyrimidine Synthesis Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Erythropoiesis-stimulating Agent [EPC] | 1 | 0.0000 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 5 | 0.0000 |